Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 2
1976 2
1977 4
1978 4
1980 2
1981 2
1982 1
1983 3
1984 3
1985 7
1986 3
1987 7
1988 9
1989 6
1990 10
1991 13
1992 11
1993 13
1994 13
1995 21
1996 21
1997 23
1998 36
1999 26
2000 19
2001 24
2002 25
2003 25
2004 24
2005 26
2006 33
2007 35
2008 30
2009 38
2010 38
2011 43
2012 35
2013 33
2014 55
2015 63
2016 71
2017 70
2018 88
2019 76
2020 60
2021 72
2022 67
2023 63
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

1,249 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Polycystic kidney disease 6 with or without polycystic liver disease"
Page 1
Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.
Mekahli D, Guay-Woodford LM, Cadnapaphornchai MA, Greenbaum LA, Litwin M, Seeman T, Dandurand A, Shi L, Sikes K, Shoaf SE, Schaefer F. Mekahli D, et al. Clin J Am Soc Nephrol. 2023 Jan 1;18(1):36-46. doi: 10.2215/CJN.0000000000000022. Clin J Am Soc Nephrol. 2023. PMID: 36719158 Free PMC article. Clinical Trial.
BACKGROUND: Tolvaptan slows expansion of kidney volume and kidney function decline in adults with autosomal dominant polycystic kidney disease (ADPKD). ...CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Safety, Pharmacokinetics, Tolerabili …
BACKGROUND: Tolvaptan slows expansion of kidney volume and kidney function decline in adults with autosomal dominant polycy …
Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease.
Hwang YH, Conklin J, Chan W, Roslin NM, Liu J, He N, Wang K, Sundsbak JL, Heyer CM, Haider M, Paterson AD, Harris PC, Pei Y. Hwang YH, et al. J Am Soc Nephrol. 2016 Jun;27(6):1861-8. doi: 10.1681/ASN.2015060648. Epub 2015 Oct 9. J Am Soc Nephrol. 2016. PMID: 26453610 Free PMC article.
Renal disease variability in autosomal dominant polycystic kidney disease (ADPKD) is strongly influenced by the gene locus (PKD1 versus PKD2). ...We screened these families for PKD1 and PKD2 mutations and reviewed the clinical outcomes of the probands …
Renal disease variability in autosomal dominant polycystic kidney disease (ADPKD) is strongly influenced by the …
Type of PKD1 mutation influences renal outcome in ADPKD.
Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y. Cornec-Le Gall E, et al. J Am Soc Nephrol. 2013 May;24(6):1006-13. doi: 10.1681/ASN.2012070650. Epub 2013 Feb 21. J Am Soc Nephrol. 2013. PMID: 23431072 Free PMC article.
Autosomal dominant polycystic kidney disease (ADPKD) is heterogeneous with regard to genic and allelic heterogeneity, as well as phenotypic variability. ...
Autosomal dominant polycystic kidney disease (ADPKD) is heterogeneous with regard to genic and allelic heterogeneity, a …
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Carrera P, Calzavara S, Magistroni R, den Dunnen JT, Rigo F, Stenirri S, Testa F, Messa P, Cerutti R, Scolari F, Izzi C, Edefonti A, Negrisolo S, Benetti E, Alibrandi MT, Manunta P, Boletta A, Ferrari M. Carrera P, et al. Sci Rep. 2016 Aug 8;6:30850. doi: 10.1038/srep30850. Sci Rep. 2016. PMID: 27499327 Free PMC article.
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common hereditary kidney disease. ...Among patients with pathogenic variants, in 301 (85.5%) the disease is associated with PKD1, 196 (55.7%) truncating, 81 (23%) non trunca …
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common hereditary kidney disease. ...Amo …
Autosomal dominant polycystic kidney disease in Colombia.
Camargo JT, González CA, Herrera L, Yomayusa-González N, Ibañez M, Valbuena-García AM, Acuña-Merchán L. Camargo JT, et al. BMC Nephrol. 2023 Jul 17;24(1):211. doi: 10.1186/s12882-023-03266-3. BMC Nephrol. 2023. PMID: 37460967 Free PMC article.
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of chronic kidney disease (CKD) that requires dialysis. ...The objective was to establish the prevalence, geographic location, and ethnic groups of …
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of chronic kidney …
Gender Differences in Liver Transplantation Outcomes in Polycystic Liver Disease.
Chauhan M, Zhang T, Thuluvath PJ. Chauhan M, et al. Dig Dis Sci. 2022 Jul;67(7):3445-3454. doi: 10.1007/s10620-021-07125-9. Epub 2021 Jun 30. Dig Dis Sci. 2022. PMID: 34191186
BACKGROUND: In this study, our objective was to determine gender differences in the outcomes of patients with PLD undergoing liver (LT) or liver/kidney transplantation (SLK). METHODS: We analyzed the UNOS datasets of all adults who had transplanted for PLD between 1988 and …
BACKGROUND: In this study, our objective was to determine gender differences in the outcomes of patients with PLD undergoing liver (LT) or l …
Autosomal Dominant Polycystic Kidney Disease Does Not Significantly Alter Major COVID-19 Outcomes among Veterans.
Cui X, Gallini JW, Jasien CL, Mrug M. Cui X, et al. Kidney360. 2021 Apr 28;2(6):983-988. doi: 10.34067/KID.0007282020. eCollection 2021 Jun 24. Kidney360. 2021. PMID: 35373094 Free PMC article.
Autosomal dominant polycystic kidney disease (ADPKD) was not a significant, independent risk factor for the four major outcomes studied among veterans with confirmed coronavirus disease 2019 (COVID-19).ADPKD did not significantly increase the risk for …
Autosomal dominant polycystic kidney disease (ADPKD) was not a significant, independent risk factor for the four major …
Young-Adult Polycystic Kidney Disease is Associated with Major Cardiovascular Complications.
Chuang YW, Yu TM, Huang ST, Sun KT, Lo YC, Fu PK, Lee BJ, Chen CH, Lin CL, Kao CH. Chuang YW, et al. Int J Environ Res Public Health. 2018 May 3;15(5):903. doi: 10.3390/ijerph15050903. Int J Environ Res Public Health. 2018. PMID: 29751520 Free PMC article.
Background: Patients with polycystic kidney disease (PKD) might have a risk of cardiovascular diseases because several cardiovascular risk factors are occasionally associated with PKD patients. ...Methods: Patients aged ≥20 years who were newly …
Background: Patients with polycystic kidney disease (PKD) might have a risk of cardiovascular diseases because s …
Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
Rangan GK, Lopez-Vargas P, Nankivell BJ, Tchan M, Tong A, Tunnicliffe DJ, Savige J. Rangan GK, et al. Semin Nephrol. 2015 Nov;35(6):524-37. doi: 10.1016/j.semnephrol.2015.10.002. Semin Nephrol. 2015. PMID: 26718155 Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited cause of renal failure in adults, and is due to loss-of-function mutations in either the PKD1 or PKD2 genes, which encode polycystin-1 and polycystin-2, respectively. ...Over the …
Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited cause of renal failure in adults, and i …
Overweight and Obesity and Progression of ADPKD.
Nowak KL, Steele C, Gitomer B, Wang W, Ouyang J, Chonchol MB. Nowak KL, et al. Clin J Am Soc Nephrol. 2021 Jun;16(6):908-915. doi: 10.2215/CJN.16871020. Epub 2021 Jun 11. Clin J Am Soc Nephrol. 2021. PMID: 34117082 Free PMC article.
BACKGROUND AND OBJECTIVES: On the basis of earlier observations, we evaluated the association between overweight and obesity and rapid progression of autosomal dominant polycystic kidney disease in participants in the Tolvaptan Efficacy and Safety in Manageme …
BACKGROUND AND OBJECTIVES: On the basis of earlier observations, we evaluated the association between overweight and obesity and rapid progr …
1,249 results